HEPATORENAL SYNDROME
Clinical trials for HEPATORENAL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HEPATORENAL SYNDROME trials appear
Sign up with your email to follow new studies for HEPATORENAL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a blood pressure drug save kidneys in liver patients?
Disease control OngoingThis study tests if ambrisentan, a drug already used for lung blood pressure, can help people with hepatorenal syndrome—a serious kidney problem that can happen in advanced liver disease. About 54 adults will get either ambrisentan or the standard treatment terlipressin while in …
Matched conditions: HEPATORENAL SYNDROME
Phase: PHASE2 • Sponsor: Noorik Biopharmaceuticals AG • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
New device hopes to help kidneys in liver patients
Disease control TerminatedThis study tests a device called the Selective Cytopheretic Device (SCD) in 10 ICU patients with acute kidney injury and hepatorenal syndrome. The device filters certain white blood cells from the blood for 7 days to see if it improves kidney function and blood circulation. The m…
Matched conditions: HEPATORENAL SYNDROME
Phase: NA • Sponsor: Lenar Yessayan • Aim: Disease control
Last updated May 22, 2026 13:50 UTC